Northwestern Mutual Wealth Management Co. Has $2.37 Billion Stock Position in Chemed Corporation $CHE

Northwestern Mutual Wealth Management Co. increased its position in shares of Chemed Corporation (NYSE:CHE) by 2,444,879.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,550,103 shares of the company’s stock after buying an additional 5,549,876 shares during the period. Chemed accounts for approximately 1.2% of Northwestern Mutual Wealth Management Co.’s holdings, making the stock its 14th biggest position. Northwestern Mutual Wealth Management Co. owned about 0.39% of Chemed worth $2,374,667,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. JPMorgan Chase & Co. lifted its position in Chemed by 122.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock worth $223,856,000 after acquiring an additional 275,423 shares during the last quarter. AQR Capital Management LLC grew its position in shares of Chemed by 160.9% in the second quarter. AQR Capital Management LLC now owns 201,041 shares of the company’s stock valued at $97,893,000 after purchasing an additional 123,982 shares during the last quarter. M&T Bank Corp increased its stake in shares of Chemed by 10,291.1% in the fourth quarter. M&T Bank Corp now owns 85,934 shares of the company’s stock worth $36,768,000 after purchasing an additional 85,107 shares during the period. Arrowstreet Capital Limited Partnership increased its stake in shares of Chemed by 740.9% in the third quarter. Arrowstreet Capital Limited Partnership now owns 95,573 shares of the company’s stock worth $42,792,000 after purchasing an additional 84,208 shares during the period. Finally, Epoch Investment Partners Inc. lifted its position in shares of Chemed by 29.4% during the 3rd quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company’s stock worth $137,579,000 after purchasing an additional 69,878 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares in the company, valued at $37,993,927.47. This trade represents a 2.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 3.33% of the stock is currently owned by company insiders.

Chemed Stock Up 1.9%

NYSE:CHE opened at $434.43 on Friday. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $583.96. The stock’s fifty day simple moving average is $396.73 and its 200-day simple moving average is $425.22. The firm has a market capitalization of $5.76 billion, a P/E ratio of 23.67, a P/E/G ratio of 1.60 and a beta of 0.54.

Chemed (NYSE:CHE) last released its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. During the same quarter in the prior year, the firm posted $5.63 earnings per share. The company’s quarterly revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities research analysts expect that Chemed Corporation will post 22.3 earnings per share for the current year.

Analysts Set New Price Targets

CHE has been the subject of several recent analyst reports. Royal Bank Of Canada increased their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Oppenheimer reduced their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Finally, Wall Street Zen raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, Chemed currently has a consensus rating of “Hold” and an average target price of $501.50.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.